Philip Helliwell is currently Associate Professor in Rheumatology at the University of Leeds, UK, and Honorary Consultant Rheumatologist for the Leeds Teaching Hospitals and Bradford Teaching Hospitals NHS Trust.
Dr Helliwell qualified in Oxford in 1972 and worked initially in London before returning to work in his native Yorkshire in medical physics. After a period working in Australia and New Zealand he returned in 1985 to Leeds to join Prof Verna Wright and to work on psoriatic arthritis and biomechanics.
Dr Helliwell is a member of the Assessment of SpondyloArthritis international Society (ASAS) and co-founder and President of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). He established and led the ClASsification criteria for Psoriatic ARthritis (CASPAR) study for classification of psoriatic arthritis. He has worked with GRAPPA in developing single and composite outcome measures in psoriatic arthritis and completed the first treat to target strategy study in early psoriatic arthritis, TIght COntrol of Psoriatic Arthritis (TICOPA).
Dr Helliwell is co-founder and co-lead for the Postgraduate Diploma in Rheumatology and Musculoskeletal Medicine at the University of Bradford, UK, and is an active member of the Bradford and Airedale Musculoskeletal Alliance, a tier 2 service provided to general practitioners in the designated geographical area.
Dr Helliwell is co-founder of the Leeds Foot and Ankle StudiEs in Rheumatology (FASTER) group and has published widely on foot and ankle problems in inflammatory arthritis including rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis. He has contributed to several guidelines on management of foot and ankle problems in the UK.
Dr Helliwell has published over 300 peer reviewed papers. Current and past research in psoriatic arthritis includes treatment paradigms, clinical features and classification of psoriatic arthritis and community based studies of psoriasis and psoriatic arthritis. He has also published on biomechanics of joints, gait assessment and foot disorders in inflammatory and non-inflammatory arthritis, and epidemiology of rheumatic diseases.